Biorevert Inc. was found with proven records of scientific achievements in cancer and drug discovery platform to identify first-in-class targets and their mechanism of actions through computational simulation and analysis. We currently have several pipelines in colon, lung, and liver cancers for developing small molecules (hit) and gene therapies (hit-to-lead) that can revert cancer cells into normal functioning cells.